Agios Pharmaceuticals

Developing therapies for rare and genetically defined diseases.

H-1B sponsor history — This employer has had H-1B petitions approved by USCIS in the last five fiscal years, per the USCIS H-1B Employer Data Hub. The approval belongs to the employer and is not a commitment to sponsor this role.
Discussion
biotechpharmaceuticals

Company facts

Founded
2008
Employees
540
Headquarters
United States
Type
Public
Listed
NASDAQ: AGIO

About

Agios Pharmaceuticals is a commercial‑stage biopharmaceutical company specializing in the development of innovative medicines for rare diseases, with a particular focus on hematology and cellular metabolism. Leveraging deep scientific expertise and real‑world insights, Agios advances a growing pipeline of therapies designed to address the unmet needs of rare disease communities, delivering treatments that have the potential to transform patients’ lives. The company’s collaborative culture and strong partnerships with patients, advocacy groups, and research institutions underpin its commitment to bold, science‑driven solutions that create lasting value for both patients and employees.

5 jobs

Tailor your CV for this role?

We couldn't check your fit for this role — add a CV to your profile to see it next time.

A new version of freehire is available